The changes of resistin, blood fat and hepatic function in patients with diabetes mellitusⅡ

Xuan GUO,Guixiang Fan,Gang Wang,Yukang Yuan,Linchuan Wang,Yuzhen Luo

DOI: https://doi.org/10.3969/j.issn.1671-8259.2005.03.016

2005-01-01

Abstract:Objective: To study the changes of resistin, blood fat and hepatic function in patients with type 2 diabetes mellitus. Methods: Enzyme linked immunosorbent assay (ELISA) was used to determine the content of resistin in peripheral blood. Radio immunoassay was used to determine the content of insulin. Oxydase or chemical method was used to determine blood sugar, and automatic analytical instrument was used to determine blood sugar, blood fat and hepatic function. Results: Blood-fasting sugars in patients with type 2 diabetes mellitus (8.85±3.21 mmol/L) increased significantly (P<0.01) compared with the control group(5.04±1.06 mmol/L), so did insulin levels (11.12±4.54 mU/L) compared with the control group (6.46±1.48 mU/L) (P<0.01). The contents of resistin in the patient group (23.06±9.34 μg/L) were significantly higher than those in the control group (9.89± 4.47 μg/L) (P<0.01). CHOs in the patient group and in the control group were (5.51±1.37 )mmol/L and (3.72 ±0.62) mmol/L, respectively; TGs were (2.48±1.60) mmol/L and (1.50±1.01) mmol/L, respectively; and ALBs were (28.49±41.18) mg/24h and (4.63±2.28) mg/24h, respectively. CHOs, TGs, and ALBs increased significantly in the patient group (P<0.05). There were no significant difference in ASTs, ALTs, HDL-Cs and LP-As between the test group and the control group (P>0.05). Conclusion: Disorders of internal environment exist in patients with type 2 diabetes mellitus. Contents of resistin, ALB, and blood fat are higher in the patients than those in the controls.